original title:
Yunnan: Restrict the purchase of antipyretic drugs and new corona antigen detection reagents
China News Service, Kunming, December 25 (Xiong Jiaxin) The Department of Commerce of Yunnan Province issued an announcement on the 24th, in response to the increased demand for fever-reducing drugs and new reagents for detecting the antigen of the corona in the province, in order to effectively respond to the shortage of urgent drugs on the market to fight the epidemic, ensure people’s demand for drugs, optimize drug allocation, reduce unnecessary hoarding of urgent drugs, and limit the purchase of antipyretic drugs and new corona antigen detection reagents from now.
According to the notice, as of December 24, when consumers buy ibuprofen capsules/granules, ibuprofen suspension, Lianhua Qingwen and new corona antigen detection reagents in pharmacies, they must use the application portal program of the Yunnan Province new crown patient protection service (WeChat applet) for real name registration. Purchase no more than 1 pack of ibuprofen (including extended-release tablets, capsules and granules) per person within seven days, no more than 1 bottle of ibuprofen suspension, no more than 2 boxes of Lianhua Qingwen capsules (granules), COVID- 19 antigen tests Reagents do not exceed 6 doses. If the purchase exceeds the amount, the system will give a warning.
All retail pharmacies must inform customers of drug name, usage and dosage, expiration date, adverse reactions and contraindications, and fully play the role of drug filling station for people’s livelihood to drive people to use drugs rationally. All retail pharmacies must strictly implement the drug operation quality management standards, and must not take the opportunity to raise prices or increase sales in disguise. The relevant commercial departments of all cities (counties, districts) must cooperate with market supervision and management departments to strengthen market inspections to ensure that this work is fully implemented.
